Nalaganje...

The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas

Malignant gliomas are devastating neoplasia with limited curative treatment options. Temozolomide (TMZ, Temcat(®), Temodal(®) or Temodar(®)) is a first-line treatment for malignant gliomas but the development of drug resistance remains a major concern. Activating transcription factor 4 (ATF4) is a c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Chen, Daishi, Rauh, Manfred, Buchfelder, Michael, Eyupoglu, Ilker Y., Savaskan, Nicolai
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584239/
https://ncbi.nlm.nih.gov/pubmed/28881638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17737
Oznake: Označite
Brez oznak, prvi označite!